A Czyrski, T Hermann, B Rubis, M Rybczynska… - Pharmazie, 2011 - Govi-Verlag Papaverine hydrochloride is used as a spasmolytic agent in the treatment of acute renal colic ( Snir et al. 2008 ). It is an unstable drug and can be oxidized easily to papaverinol and papaveraldine (Machovičová and Parrák 1955; Piotrowska 2006 ). Some time ago, the new derivatives ... Related articles - All 3 versions
CM Moran, ME Mahla, B Reichwage, S Lewis… - Journal of …, 2011 - thejns.org Papaverine has been associated with transient cranial nerve dysfunction after topical application during craniotomy. The authors report similar dysfunction after the use of papaverine affected brainstem structures. Two patients undergoing craniotomy for clipping of an aneurysm ... Related articles - All 2 versions
YT Hsu, G Liao, X Bi, T Oka, S Tamura… - Neuropharmacology, 2011 - Elsevier The phosphodiesterase 10A (PDE10A) is highly expressed within dopaminoreceptive medium spiny neurons (MSNs) of the striatum, which are implicated in various neurodegenerative diseases and psychiatric disorders, such as Huntington's disease and schizophrenia. With its dual ...
FJJ Bihel, H Justiniano, M Schmitt, M Hellal… - Bioorganic & Medicinal …, 2011 - Elsevier Accepted Manuscript New PDE4 inhibitors based on pharmacophoric similarity between Papaverine and Tofisopam Fr d ric JJ Bihel, H l ne Justiniano, Marti Schm tt, Malik Hellal, Mohamed A. Ibrahim, Claire Lugnier, Jean-Jacqu s Bourguignon PII: S0960-894X(11)01121-8 DOI: ...
K Itoh, T Ishima, J Kehler… - Brain research, 2011 - Elsevier Papaverine, an inhibitor of phosphodiesterase (PDE) 10A, is gaining attention for its potential in the treatment of neuropsychiatric diseases such as schizophrenia. However, the precise mechanisms underlying the putative neuroprotective/neurotrophic actions of papaverine remain ... All 3 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
